相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators
Sumanta Garai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Axially Chiral Cannabinols: A New Platform for Cannabinoid-Inspired Drug Discovery
Primali V. Navaratne et al.
CHEMMEDCHEM (2020)
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief
Francesca Gado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Diarylureas Containing 5-Membered Heterocycles as CB1 Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation
Thuy Nguyen et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA
Samuel D. Banister et al.
DRUG TESTING AND ANALYSIS (2019)
Plant-Based Modulators of Endocannabinoid Signaling
Christopher W. Cunningham
JOURNAL OF NATURAL PRODUCTS (2019)
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators
Chih-Chung Tseng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice
Erica Zamberletti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Preclinical safety and efficacy of cannabidivarin for early life seizures
Megan N. Huizenga et al.
NEUROPHARMACOLOGY (2019)
Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor
George Amato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure-Activity Relationship Studies
Dow P. Hurst et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Cannabichromene is a cannabinoid CB2 receptor agonist
Michael Udoh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
Francesca Gado et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
Erica Zamberletti et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties
Aya E. Ghonim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids
Michael Moir et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Practical approaches to evaluating and optimizing brain exposure in early drug discovery
Burgess B. Freeman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications
Vivek S. Kumawat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators
Thuy Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE CHEMICAL BIOLOGY (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
Synthetic cannabinoids in hair - Pragmatic approach for method updates, compound prevalences and concentration ranges in authentic hair samples
Florian Franz et al.
ANALYTICA CHIMICA ACTA (2018)
Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor
Noureldin Saleh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor
Annalaura Sabatucci et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bihua Bie et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
Gustavo Gonzalez-Cuevas et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain
Hong Zhang et al.
PAIN (2018)
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons
Jose Mitjavila et al.
PHARMACOLOGICAL RESEARCH (2018)
The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects
Lirit N. Franks et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
Gemma Navarro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells
Philippe Diaz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ion mobility spectrometry and high resolution mass-spectrometry as methodologies for rapid identification of the last generation of new psychoactive substances
A. Yanini et al.
JOURNAL OF CHROMATOGRAPHY A (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Exploring 6-Azaindole and 7-Azaindole Rings for Developing Cannabinoid Receptor 1 Allosteric Modulators
Sri Sujana Immadi et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability
Florian Franz et al.
DRUG TESTING AND ANALYSIS (2017)
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen et al.
MEDICINAL RESEARCH REVIEWS (2017)
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies
Hai-Yan Qian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
Thuy Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1
Leepakshi Khurana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies
Andrea Martella et al.
MOLECULAR PHARMACOLOGY (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators
Thomas E. Gamage et al.
NEUROPHARMACOLOGY (2017)
Synthetic Pot: Not Your Grandfather's Marijuana
Benjamin M. Ford et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain
Sangdon Han et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
Wei Chen et al.
FRONTIERS IN PHARMACOLOGY (2017)
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
Vanessa Petrucci et al.
SCIENTIFIC REPORTS (2017)
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
Simone Bertini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Goutham R. Adelli et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide(3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer
Gavin McLaughlin et al.
DRUG TESTING AND ANALYSIS (2016)
Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole5-carboxamide and the relevance of predicted 13C NMR shifts - a case study
Ulrich Girreser et al.
DRUG TESTING AND ANALYSIS (2016)
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists
Bin Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists
Jay M. Matthews et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor
Chang-Jiang Qiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice
Cornelius Hess et al.
FORENSIC TOXICOLOGY (2016)
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Herbert H. Seltzman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The endocannabinoid system and neuropathic pain
Rafael Maldonado et al.
PAIN (2016)
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile
M. Gomez-Canas et al.
PHARMACOLOGICAL RESEARCH (2016)
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
Ziva D. Cooper
CURRENT PSYCHIATRY REPORTS (2016)
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3
Muneer Ahamed et al.
FRONTIERS IN NEUROSCIENCE (2016)
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome
Yasuhiro Iwata et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor
Shuang Han et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor
Shuang Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor
Roger Slavik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Zoran Rankovic
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska-Jankowska et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice
Jenny L. Wiley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
Thomas F. Gamage et al.
BEHAVIOURAL PHARMACOLOGY (2014)
The endocannabinoid system modulates stress, emotionality, and inflammation
Molly S. Crowe et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING
Derek M. Shore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
Alexandros Makriyannis
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Optimization of Chemical Functionalities of Indole-2-carboxamides To Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1)
Leepakshi Khurana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Latest Progress in the Identification of Novel Synthetic Ligands for the Cannabinoid CB2 Receptor
Shuang Han et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2014)
Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids
Jenny L. Wiley et al.
LIFE SCIENCES (2014)
Synthetic cannabinoids: Analysis and metabolites
Mahmoud A. ElSohly et al.
LIFE SCIENCES (2014)
Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures
Sarah Rosenthaler et al.
NEUROTOXICOLOGY AND TERATOLOGY (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Peripherally restricted CB1 receptor blockers
Robert J. Chorvat
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
Sean P. Hollinshead et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Trisubstituted Sulfonamides: A New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists
Qin Ouyang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ )-induced increases in epilepsy-related gene expression
Naoki Amada et al.
PEERJ (2013)
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie et al.
MOLECULAR PHARMACOLOGY (2013)
JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities
Robert J. Chorvat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors
Mark Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor
Francesco Piscitelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure-activity relationships, physicochemical properties and biological activity
Antoni R. Blaazer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists
Mario van der Stelt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha(2)-adrenoceptor agonist and moderately potent 5HT(1A) receptor antagonist
M. G. Cascio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Endocannabinoid signalling: has it got rhythm?
Linda K. Vaughn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
Kalpana S. Paudel et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Depression-like phenotype following chronic CB1 receptor antagonism
Chad E. Beyer et al.
NEUROBIOLOGY OF DISEASE (2010)
The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Matthew N. Hill et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists
Yuan Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Allosterism and cannabinoid CB1 receptors:: the shape of things to come
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:: A potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration
Edward K. Dziadulewicz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
The cannahinergic system as a target for anti-inflammatory therapies
Dai Lu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
3-indolyl-1-naphthylmethanes:: New cannabimimetic Indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor
JW Huffman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
MM Aung et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
分享论文
